The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Here's a roundup of top developments in the biotech space over the last 24 hours:
Moderna Reports Collab With Metagenomi To Develop Next Gen In Vivo Gene Editing Therapeutics, No Terms Disclosed
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies to accelerate the development of in vivo gene editing
Why Moderna Shares Are Trading Lower Today
Moderna Inc (NASDAQ: MRNA) is trading lower Monday morning after the U.S. Food and Drug Administration delayed approval of the company's Emergency Use Authorization request for the use of its COVID-19 vaccine in adolescents 12 to 17 years of age.
FDA Delays Approval For Moderna’s COVID-19 Shot In Teenagers: What You Need To Know
Moderna Inc (NASDAQ:MRNA) said that the FDA would require additional time to complete its assessment of its COVID-19 vaccine for use…
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Moderna Provides Update on Timing of U.S. Emergency Use Authorization of Its Covid-19 Vaccine for Adolescents; Says FDA Notified Moderna That Review May Not Be Completed Before January 2022
Moderna, Inc. (NASDAQ: MRNA) today provided an update that the U.S.
Moderna To Supply Additional COVID-19 Vaccine Doses To COVAX Alliance
Moderna Inc (NASDAQ:MRNA) has announced an agreement with Gavi, the Vaccine Alliance, to supply up to 116.5 million doses of its…
Moderna Reports Added Supply For Q2’22 Of Vaccine For COVAX Facility
Q2 deliveries almost double – a further 56.5 million in options exercised by COVAX, for a total 116.5 million doses for delivery in the second quarter of 2022
Per the original APA, COVAX Facility retains options